Does Dr. RICHARD BALIKIAN have financial conflicts of interest?

Dr. RICHARD BALIKIAN (M.D.) has received a total of $16,121 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $16,121 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RICHARD BALIKIAN?

According to CMS Open Payments data, Dr. RICHARD BALIKIAN received funding from ALLERGAN ($11,772), ABBVIE ($4,227), and GALDERMA LABORATORIES, L.P ($55).

Does Dr. RICHARD BALIKIAN receive research grants or speaking fees?

Dr. RICHARD BALIKIAN has received $16,121 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RICHARD BALIKIAN

M.D.Real-Time Hydrated

Specialty: Otolaryngology, Otolaryngology/Facial Plastic Surgery

Practice Location: INDIANAPOLIS, IN 46290

NPI Number: 1740334317

LIFETIME INDUSTRY VALUE

$16,121

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BALIKIAN is a verified Otolaryngology, Otolaryngology/Facial Plastic Surgery practitioner based in INDIANAPOLIS, IN.

Between 2021 and 2024, Dr. BALIKIAN had an overall industry promotional and research financial footprint of $16,121 as recorded in the federal CMS Open Payments database.

$16,121 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BALIKIAN's primary funding source is ALLERGAN, which accounts for $11,772 (representing 73% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ALLERGAN

Rank 1

$11,772

73%

ABBVIE

Rank 2

$4,227

26.2%

GALDERMA LABORATORIES, L.P

Rank 3

$55

0.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.